not losing weight on tirzepatide 2.5 stopped working 🚨 Patient Information: Tirzepatide (Mounjaro®) 🚨 Tirzepatide is being offered under the following strict criteria: ✓ You have at least 4 of these 5 conditions – Type 2 Diabetes, Hypertension (high Why Am I Not Losing

The goal is to remove the tumor with clear margins to prevent recurrence

#semaglutide #wegovy #ozempic #habitual #novonordisk #glp1 #heartfailure #HFpEF #obesity #weightmanagement #metabolichealth #cardiovascularhealth Whoa, that's fascinating research

Study: TripleHormone Receptor Agonist Retatrutide for Obesity (Phase 2 Trial, NEJM) Drug: Retatrutide a triple agonist (GLP-1, GIP, and glucagon receptors) Key Findings: Up to 28.7% mean weight loss at higher doses Marked improvements in insulin sensitivity and cardiometabolic risk factors Weight loss approaching outcomes seen with bariatric surgery, without surgery What makes Retatrutide unique is its triple-hormone mechanism, simultaneously targeting appetite regulation, energy expenditure, and glucose metabolism

Biopsy: Fine needle aspiration (FNA) or core needle biopsy can obtain cells for diagnosis if cancer or atypical infection is suspected